Ardelyx Inc.

(ARDX) Trade

By |

Profile

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Contact Information

Website: www.ardelyx.com
Email: monique@thrustsc.com
Main Phone: +1 510 745-1700
Address: 34175 Ardenwood Boulrvard
Address 2: Suite 200
State: CA
City / Town: Fremont
Country: USA
Postal Code: 94555

Issuer Information

Exchange: NSD
CEO: Michael G. Raab
Employees: 75
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.43 $ -0.01 (-0.41%)
Last Price 2.43 Change $ -0.01 Change % -0.41 Tick N/A
Bid 2.42 Bid Size 300.00 Ask 2.44 Ask Size 100.00
Open 2.50 High 2.58 Low 2.34 Prev Close 2.44
Last Trade Volume 109,930 52 Wk Hi 8.10 52 Wk Low 2.26
Market Cap 151 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 62,134,530.00 EPS (TTM) -0.96 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 23 33
Number of Buys 23 30
Number of Sells 0 3
Net Activity 9583332 9780506
Last 10 Buys Shares
Peter J. Barris 1,000
Peter J. Barris 1,000
Peter J. Barris 1,000
Forest Baskett 1,000
Forest Baskett 1,000
M. James Barrett 1,000
Harry R. Weller 1,000
Ravi Viswanathan 1,000
Ravi Viswanathan 1,000
Forest Baskett 1,000
Last 10 Sell Shares
David P. Rosenbaum 1,000
Reginald Seeto 1,000
Forest Baskett 1,000
David P. Rosenbaum 1,000
David P. Rosenbaum 1,000
Jeremy S. Caldwell 1,000
Jeffrey Jacobs 1,000
Paul Korner 1,000
David P. Rosenbaum 1,000
Jeremy S. Caldwell 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 17 17 17 17
Low Target Price Estimate 12 12 12 12
Mean Target Price Estimate 14.2 14.2 14.2 14.2
Standard Deviation 2.17 2.17 2.17 2.17
Date of Most Recent Estimate 05/25/18 05/25/18 05/22/18 05/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1